Evaluation of Selected Honey and One of Its Phenolic Constituent Eugenol against L1210 Lymphoid Leukemia

Table 1

Antileukemic activity of selected honey and eugenol.

Treatment groups	Median survival time	%	Inference
Sample B (50% v/v i.p.)	8.0 days	102.56	Nonsignificant activity
Sample C (50% v/v)	8.16 days	104.61	Nonsignificant activity
Eugenol (100 mg/kg i.p.)	8.6 days	110.25	Nonsignificant activity
5-FU (20 mg/kg i.p.)	13.0 days	166.66	Significant activity
Control (NS 0.2 mL i.p.)	7.8 days